InvestorsHub Logo
Followers 1
Posts 191
Boards Moderated 0
Alias Born 05/09/2012

Re: smallbio post# 290

Sunday, 07/14/2019 10:16:21 AM

Sunday, July 14, 2019 10:16:21 AM

Post# of 660
I think they need this new open label trial to get 300 patients for at least 6 month & use the STRIDE-1 trial to get 100 patients for at least 1 year.

STRIDE-1 design is to have 125 patients on AXS-05 & 125 on Bupropion.

One question is: are patients in the trial on the drug continue dose after 6 weeks over or they stop dose?

Second question is: can AXSM combine this open label trial & STRIDE-1 to get to total of 300 to satisfy safety requirement?


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXSM News